Teoh, E., Bridges, E., Morotti, M., Zois, C., Lord, S., Gleeson, F., & Harris, A. (2017). Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer. Springer.
Cita Chicago (17th ed.)Teoh, EJ, EM Bridges, M. Morotti, CE Zois, SR Lord, FV Gleeson, i AL Harris. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
Cita MLA (9th ed.)Teoh, EJ, et al. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
Atenció: Aquestes cites poden no estar 100% correctes.